| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| STOLL BA et al. | ORAL CONTRACEPTIVES AND LIVER DAMAGE. | 1965 | Br Med J | pmid:14245215 |
| EHTISHAMUDDIN M | VERTEBRAL-ARTERY THROMBOSIS AND ORAL CONTRACEPTIVES. | 1965 | Br Med J | pmid:14257414 |
| Oral contraceptives--choice of product. | 1968 | Br Med J | pmid:4171189 | |
| Briggs MH and Briggs M | Contraceptives and serum proteins. | 1970 | Br Med J | pmid:5454345 |
| Kenyon IE | Unplanned pregnancy in an epileptic. | 1972 | Br Med J | pmid:5015305 |
| Hormones in advanced cancer. | 1971 | Br Med J | pmid:4253671 | |
| PAROS NL | SIDE-EFFECTS OF ORAL CONTRACEPTIVES. | 1964 | Br Med J | pmid:14088325 |
| Vosnides G et al. | Letter: Liver hamartomas in patients on oral contraceptives. | 1974 | Br Med J | pmid:4414279 |
| Cope E | Management of abnormal bleeding. | 1971 | Br Med J | pmid:5556066 |
| Clinicopathological conference. A patient's life. | 1975 | Br Med J | pmid:1170920 | |
| Meade TW et al. | Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. | 1980 | Br Med J | pmid:7388443 |
| Poller L et al. | Oestrogen-progestogen oral contraception and blood clotting: a long-term follow-up. | 1971 | Br Med J | pmid:5134560 |
| ZILKHA KJ | CEREBROVASCULAR ACCIDENTS AND ORAL CONTRACEPTION. | 1964 | Br Med J | pmid:14198735 |
| HARTVEIT F | COMPLICATIONS OF ORAL CONTRACEPTION. | 1965 | Br Med J | pmid:14213119 |
| PALVA IP and MUSTALA OO | ORAL CONTRACEPTIVES AND LIVER DAMAGE. | 1964 | Br Med J | pmid:14171108 |
| Winton F | Sulpiride and the potentiation of progestogen only contraception. | 1985 | Br Med J (Clin Res Ed) | pmid:3931824 |
| Sheehan JP | Hormone replacement treatment and benign intracranial hypertension. | 1982 | Br Med J (Clin Res Ed) | pmid:6805652 |
| Kay CR | Blood pressure and contraceptive use. | 1982 | Br Med J (Clin Res Ed) | pmid:6809217 |
| Kalra PA et al. | Hepatic adenomas induced by norethisterone in patients receiving renal dialysis. | 1987 | Br Med J (Clin Res Ed) | pmid:3105752 |
| Payne MR et al. | Sulpiride and the potentiation of progestogen only contraception. | 1985 | Br Med J (Clin Res Ed) | pmid:2994800 |
| Guillebaud J | Are there any absolute medical contraindications to the progestogen only oral contraceptive? | 1984 | Br Med J (Clin Res Ed) | pmid:6435783 |
| Magos AL et al. | Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study. | 1986 | Br Med J (Clin Res Ed) | pmid:3087550 |
| Brincat M et al. | Sex hormones and skin collagen content in postmenopausal women. | 1983 | Br Med J (Clin Res Ed) | pmid:6416400 |
| Prescott P | Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone. | 1986 | Br Med J (Clin Res Ed) | pmid:3091153 |
| MartÃnez C et al. | Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy. | 2002 | Br. J. Cancer | pmid:12237780 |
| Kristiansen G et al. | Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. | 2010 | Br. J. Cancer | pmid:20531416 |
| Althuis MD et al. | Hormonal content and potency of oral contraceptives and breast cancer risk among young women. | 2003 | Br. J. Cancer | pmid:12556959 |
| Edelstyn GA and Macrae KD | Cyclical combination chemotherapy in advanced breast cancer. | 1973 | Br. J. Cancer | pmid:4758373 |
| Lindemann K et al. | Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. | 2008 | Br. J. Cancer | pmid:18362938 |
| Seidel A et al. | Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. | 2006 | Br. J. Cancer | pmid:16685264 |
| Ewertz M et al. | Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. | 2005 | Br. J. Cancer | pmid:15785751 |
| Garcea G et al. | Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. | 2004 | Br. J. Cancer | pmid:14997198 |
| Csizmadi I et al. | The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women. | 2004 | Br. J. Cancer | pmid:14710210 |
| Denton AS et al. | Systematic review for non-surgical interventions for the management of late radiation proctitis. | 2002 | Br. J. Cancer | pmid:12107832 |
| Powles TJ et al. | The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. | 1998 | Br. J. Cancer | pmid:9683306 |
| Gillespie PJ et al. | Possible clinical implications of therapeutically induced temperature changes in continuously monitored tumour mass. (Preliminary report). | 1971 | Br. J. Cancer | pmid:5104072 |
| Lipschutz A et al. | Ovarian tumours and other ovarian changes induced in mice by two 19-nor-contraceptives. | 1967 | Br. J. Cancer | pmid:6024506 |
| Lipschutz A et al. | Pathological changes induced in the uterus of mice with the prolonged administration of progesterone and 19-nor-contraceptives. | 1967 | Br. J. Cancer | pmid:6024507 |
| Saihan EM and Burton JL | Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy. | 1980 | Br. J. Dermatol. | pmid:6448623 |
| Darlington LG | Erythema nodosum and oral contraceptives. | 1974 | Br. J. Dermatol. | pmid:4819138 |
| Burton JL and Saihan E | Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy [pproceedings]. | 1979 | Br. J. Dermatol. | pmid:157155 |
| Miller JA et al. | Anti-androgen treatment in women with acne: a controlled trial. | 1986 | Br. J. Dermatol. | pmid:2941052 |
| Stevenson JC et al. | Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers. | 2004 | Br. J. Haematol. | pmid:15009069 |
| Leach M et al. | Norethisterone therapy for bleeding due to gastrointestinal telangiectases in Glanzmann's thrombasthenia. | 1998 | Br. J. Haematol. | pmid:9504647 |
| Høibraaten E et al. | Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial. | 2001 | Br. J. Haematol. | pmid:11703344 |
| Diffey B et al. | The effect of oral contraceptive agents on the basal metabolic rate of young women. | 1997 | Br. J. Nutr. | pmid:9227183 |
| Back DJ et al. | The reduction of the enterohepatic circulation of norethisterone by antibiotics in the rat [proceedings]. | 1978 | Br. J. Pharmacol. | pmid:719259 |
| Freudenberger T et al. | Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice. | 2014 | Br. J. Pharmacol. | pmid:24923668 |
| Hirst BH et al. | Effects of a combined oestrogen-progestin preparation on gastric acid and pepsin secretion, serum gastrin concentration and biliary secretion of bile acids, phospholipids, and cholesterol in the cat. | 1979 | Br. J. Pharmacol. | pmid:367477 |
| Back DJ et al. | The interaction of antibiotics with synthetic steroids in the rat [proceedings]. | 1978 | Br. J. Pharmacol. | pmid:638363 |